Protein corona composition does not accurately predict hematocompatibility of colloidal gold nanoparticles

Nanomedicine: Nanotechnology, Biology, and Medicine

Volumn 10, Issue 7, 2014, Pages 1453-1463

  Dobrovolskaia, Marina A ^a   Neun, Barry W ^a   Man, Sonny ^a   Ye, Xiaoying ^a   Hansen, Matthew ^a   Patri, Anil K ^a   Crist, Rachael M ^a   McNeil, Scott E ^a  

^a FREDERICK NATIONAL LABORATORY FOR CANCER RESEARCH   (United States)

Author keywords

Coagulation; Complement; Hematocompatibility; Nanoparticles; Protein corona

Indexed keywords

BIOCHEMISTRY; BIOCOMPATIBILITY; COAGULATION; COLLOIDS; FIBER OPTIC SENSORS; METAL NANOPARTICLES; MOLECULAR WEIGHT; NANOPARTICLES; PROTEINS;

COLLOIDAL GOLD NANOPARTICLES; COMPLEMENT; HEMATOCOMPATIBILITY; HEMATOTOXICITY; INCUBATION TIME; NANOPARTICLE SURFACE; PROTEIN BINDING; PROTEIN CORONAS;

GOLD NANOPARTICLES;

BLOOD CLOTTING FACTOR; CARRIER PROTEIN; CELL ADHESION MOLECULE; CELL PROTEIN; COLLOIDAL GOLD; COMPLEMENT; CYTOSKELETON PROTEIN; ENZYME; GLYCOPROTEIN; GOLD NANOPARTICLE; HEAT SHOCK PROTEIN; HYALURONIC ACID BINDING PROTEIN; IMMUNOGLOBULIN; MACROGOL; PROTEIN; PROTEIN CORONA; SCLEROPROTEIN; UNCLASSIFIED DRUG; COLLOID; GOLD; MACROGOL DERIVATIVE; METAL NANOPARTICLE; PROTEIN BINDING;

ARTICLE; BIOCOMPATIBILITY; BLOOD CLOTTING; BLOOD COMPATIBILITY; COMPLEMENT ACTIVATION; COMPLEMENT BLOOD LEVEL; CONTROLLED STUDY; HUMAN; INCUBATION TIME; MASS SPECTROMETRY; MATERIAL COATING; MOLECULAR WEIGHT; NORMAL HUMAN; PLASMA PROTEIN BINDING; PREDICTION; PROTEIN ANALYSIS; PROTHROMBIN TIME; SURFACE PROPERTY; THROMBIN TIME; CHEMISTRY; COLLOID;

BLOOD COAGULATION; COLLOIDS; COMPLEMENT SYSTEM PROTEINS; GOLD; HUMANS; METAL NANOPARTICLES; POLYETHYLENE GLYCOLS; PROTEIN BINDING; PROTEINS;

EID: 84906101721     PISSN: 15499634     EISSN: 15499642     Source Type: Journal    
DOI: 10.1016/j.nano.2014.01.009     Document Type: Article

References (40)

1. Treuel L., Nienhaus G.U. Nanoparticle interaction with plasma proteins as it relates to biodistribution. Handbook of immunological properties of engineered nanomaterials. 1 2013, 151-164. World Scientific Publishing Co. Pte. Ltd., Singapore. M.A. Dobrovolskaia, S.E. McNeil (Eds.).
2. Cedervall T., Lynch I., Foy M., Berggard T., Donnelly S.C., Cagney G., et al. Detailed identification of plasma proteins adsorbed on copolymer nanoparticles. Angew Chem Int Ed Engl 2007, 46:5754-5756.
3. Goppert T.M., Muller R.H. Polysorbate-stabilized solid lipid nanoparticles as colloidal carriers for intravenous targeting of drugs to the brain: comparison of plasma protein adsorption patterns. J Drug Target 2005, 13:179-187.
4. Michaelis K., Hoffmann M.M., Dreis S., Herbert E., Alyautdin R.N., Michaelis M., et al. Covalent linkage of apolipoprotein e to albumin nanoparticles strongly enhances drug transport into the brain. J Pharmacol Exp Ther 2006, 317:1246-1253.
5. Nagayama S., Ogawara K., Minato K., Fukuoka Y., Takakura Y., Hashida M., et al. Fetuin mediates hepatic uptake of negatively charged nanoparticles via scavenger receptor. Int J Pharm 2007, 329:192-198.
6. Zensi A., Begley D., Pontikis C., Legros C., Mihoreanu L., Wagner S., et al. Albumin nanoparticles targeted with Apo E enter the CNS by transcytosis and are delivered to neurones. J Control Release 2009, 137:78-86.
7. Dobrovolskaia M.A., Patri A.K., Zheng J., Clogston J.D., Ayub N., Aggarwal P., et al. Interaction of colloidal gold nanoparticles with human blood: effects on particle size and analysis of plasma protein binding profiles. Nanomedicine 2009, 5:106-117.
8. Lundqvist M., Stigler J., Cedervall T., Berggard T., Flanagan M.B., Lynch I., et al. The evolution of the protein corona around nanoparticles: a test study. ACS Nano 2011, 5:7503-7509.
9. Casals E., Puntes V.F. Inorganic nanoparticle biomolecular corona: formation, evolution and biological impact. Nanomedicine (Lond) 2012, 7:1917-1930.
10. Gebauer J.S., Malissek M., Simon S., Knauer S.K., Maskos M., Stauber R.H., et al. Impact of the nanoparticle-protein corona on colloidal stability and protein structure. Langmuir 2012, 28:9673-9679.
11. Hoshino Y., Nakamoto M., Miura Y. Control of protein-binding kinetics on synthetic polymer nanoparticles by tuning flexibility and inducing conformation changes of polymer chains. J Am Chem Soc 2012, 134:15209-15212.
12. Jansch M., Stumpf P., Graf C., Ruhl E., Muller R.H. Adsorption kinetics of plasma proteins on ultrasmall superparamagnetic iron oxide (USPIO) nanoparticles. Int J Pharm 2012, 428:125-133.
13. Milani S., Bombelli F.B., Pitek A.S., Dawson K.A., Radler J. Reversible versus irreversible binding of transferrin to polystyrene nanoparticles: soft and hard corona. ACS Nano 2012, 6:2532-2541.
14. Deng Z.J., Liang M., Toth I., Monteiro M., Minchin R.F. Plasma protein binding of positively and negatively charged polymer-coated gold nanoparticles elicits different biological responses. Nanotoxicology 2013, 7:314-322.
15. Deng Z.J., Liang M., Toth I., Monteiro M.J., Minchin R.F. Molecular interaction of poly(acrylic acid) gold nanoparticles with human fibrinogen. ACS Nano 2012, 6:8962-8969.
16. Deng Z.J., Mortimer G., Schiller T., Musumeci A., Martin D., Minchin R.F. Differential plasma protein binding to metal oxide nanoparticles. Nanotechnology 2009, 20:455101.
17. Lundqvist M., Stigler J., Elia G., Lynch I., Cedervall T., Dawson K.A. Nanoparticle size and surface properties determine the protein corona with possible implications for biological impacts. Proc Natl Acad Sci U S A 2008, 105:14265-14270.
18. Monopoli M.P., Aberg C., Salvati A., Dawson K.A. Biomolecular coronas provide the biological identity of nanosized materials. Nat Nanotechnol 2012, 7:779-786.
19. Walczyk D., Bombelli F.B., Monopoli M.P., Lynch I., Dawson K.A. What the cell "sees" in bionanoscience. J Am Chem Soc 2010, 132:5761-5768.
20. Mahmoudi M., Saeedi-Eslami S.N., Shokrgozar M.A., Azadmanesh K., Hassanlou M., Kalhor H.R., et al. Cell "vision": complementary factor of protein corona in nanotoxicology. Nanoscale 2012, 4:5461-5468.
21. Hainfeld J.F., Slatkin D.N., Focella T.M., Smilowitz H.M. Gold nanoparticles: a new X-ray contrast agent. Br J Radiol 2006, 79:248-253.
22. Liu J., Lu Y. Colorimetric biosensors based on DNAzyme-assembled gold nanoparticles. J Fluoresc 2004, 14:343-354.
23. Paciotti G.F., Myer L., Weinreich D., Goia D., Pavel N., McLaughlin R.E., et al. Colloidal gold: a novel nanoparticle vector for tumor directed drug delivery. Drug Deliv 2004, 11:169-183.
24. Thaxton C.S., Georganopoulou D.G., Mirkin C.A. Gold nanoparticle probes for the detection of nucleic acid targets. Clin Chim Acta 2006, 363:120-126.
25. Diluzio N.R., Zilversmit D.B. Influence of exogenous proteins on blood clearance and tissue distribution of colloidal gold. Am J Physiol 1955, 180:563-565.
26. Goel R., Shah N., Visaria R., Paciotti G.F., Bischof J.C. Biodistribution of TNF-alpha-coated gold nanoparticles in an in vivo model system. Nanomedicine (Lond) 2009, 4:401-410.
27. Rygard J. Mechanism of blood clearance of colloidal gold in mice. An atoxic clinical investigation using activation analysis. Acta Radiol Suppl 1971, 308:1-240.
28. Terentyuk G.S., Maslyakova G.N., Suleymanova L.V., Khlebtsov B.N., Kogan B.Y., Akchurin G.G., et al. Circulation and distribution of gold nanoparticles and induced alterations of tissue morphology at intravenous particle delivery. J Biophotonics 2009, 2:292-302.
29. Kah J.C., Wong K.Y., Neoh K.G., Song J.H., Fu J.W., Mhaisalkar S., et al. Critical parameters in the pegylation of gold nanoshells for biomedical applications: an in vitro macrophage study. J Drug Target 2009, 17:181-193.
30. O'Neal D.P., Hirsch L.R., Halas N.J., Payne J.D., West J.L. Photo-thermal tumor ablation in mice using near infrared-absorbing nanoparticles. Cancer Lett 2004, 209:171-176.
31. Mirkin CA, Lytton-Jean AKR, Hurst SJ, inventorsMaximizing Oligonucleotide Loading on Gold Nanoparticle. USAUS Patent US2010/0099858, publication date November 9, 2009.
32. Issaq H.J., Chan K.C., Blonder J., Ye X., Veenstra T.D. Separation, detection and quantitation of peptides by liquid chromatography and capillary electrochromatography. J Chromatogr A 2009, 1216:1825-1837.
33. Vroman L., Adams A.L., Fischer G.C., Munoz P.C. Interaction of high molecular weight kininogen, factor XII, and fibrinogen in plasma at interfaces. Blood 1980, 55:156-159.
34. Blunk T., Luck M., Calvor A., Hochstrasser D.F., Sanchez J.C., Muller B.W., et al. Kinetics of plasma protein adsorption on model particles for controlled drug delivery and drug targetting. Eur J Pharm Biopharm 1996, 42:262-268.
35. Goppert T.M., Muller R.H. Adsorption kinetics of plasma proteins on solid lipid nanoparticles for drug targeting. Int J Pharm 2005, 302:172-186.
36. Harnisch S., Muller R.H. Adsorption kinetics of plasma proteins on oil-in-water emulsions for parenteral nutrition. Eur J Pharm Biopharm 2000, 49:41-46.
37. Gref R., Luck M., Quellec P., Marchand M., Dellacherie E., Harnisch S., et al. 'Stealth' corona-core nanoparticles surface modified by polyethylene glycol (PEG): influences of the corona (PEG chain length and surface density) and of the core composition on phagocytic uptake and plasma protein adsorption. Colloids Surf B: Biointerfaces 2000, 18:301-313.
38. Deng Z.J., Liang M., Monteiro M., Toth I., Minchin R.F. Nanoparticle-induced unfolding of fibrinogen promotes Mac-1 receptor activation and inflammation. Nat Nanotechnol 2011, 6:39-44.
39. Salvador-Morales C., Basiuk E.V., Basiuk V.A., Green M.L., Sim R.B. Effects of covalent functionalization on the biocompatibility characteristics of multi-walled carbon nanotubes. J Nanosci Nanotechnol 2008, 8:2347-2356.
40. Salvador-Morales C., Flahaut E., Sim E., Sloan J., Green M.L., Sim R.B. Complement activation and protein adsorption by carbon nanotubes. Mol Immunol 2006, 43:193-201.